sca6

sca6

<div class="infobox infobox-gene">
<h3>SCA6 (CACNA1A)</h3>
<table>
<tr><th>Gene Symbol</th><td>CACNA1A</td></tr>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Subunit Alpha1 A</td></tr>
<tr><th>Chromosomal Location</th><td>19p13.13</td></tr>
<tr><th>NCBI Gene ID</th><td>[774](https://www.ncbi.nlm.nih.gov/gene/774)</td></tr>
<tr><th>OMIM</th><td>[117013](https://www.omim.org/entry/117013)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000159289](https://www.ensembl.org/Homo_sapiens/Gene?g=ENSG00000159289)</td></tr>
<tr><th>UniProt</th><td>[Q00978](https://www.uniprot.org/uniprotkb/Q00978)</td></tr>
<tr><th>Protein Class</th><td>Voltage-gated calcium channel, P/Q-type (CaV2.1)</td></tr>
<tr><th>Expression</th><td>Cerebellum (Purkinje cells), brainstem, cerebral cortex</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

SCA6 (Spinocerebellar Ataxia Type 6) is caused by CAG trinucleotide repeat expansions in the CACNA1A gene, which encodes the P/Q-type voltage-gated calcium channel (CaV2.1)[@zhuchenko1997]. This channel is essential for synaptic transmission, particularly in [Purkinje cells](/cell-types/purkinje-cells) of the cerebellum, where it mediates calcium influx necessary for neurotransmitter release and dendritic excitability.

sca6

<div class="infobox infobox-gene">
<h3>SCA6 (CACNA1A)</h3>
<table>
<tr><th>Gene Symbol</th><td>CACNA1A</td></tr>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Subunit Alpha1 A</td></tr>
<tr><th>Chromosomal Location</th><td>19p13.13</td></tr>
<tr><th>NCBI Gene ID</th><td>[774](https://www.ncbi.nlm.nih.gov/gene/774)</td></tr>
<tr><th>OMIM</th><td>[117013](https://www.omim.org/entry/117013)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000159289](https://www.ensembl.org/Homo_sapiens/Gene?g=ENSG00000159289)</td></tr>
<tr><th>UniProt</th><td>[Q00978](https://www.uniprot.org/uniprotkb/Q00978)</td></tr>
<tr><th>Protein Class</th><td>Voltage-gated calcium channel, P/Q-type (CaV2.1)</td></tr>
<tr><th>Expression</th><td>Cerebellum (Purkinje cells), brainstem, cerebral cortex</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

SCA6 (Spinocerebellar Ataxia Type 6) is caused by CAG trinucleotide repeat expansions in the CACNA1A gene, which encodes the P/Q-type voltage-gated calcium channel (CaV2.1)[@zhuchenko1997]. This channel is essential for synaptic transmission, particularly in [Purkinje cells](/cell-types/purkinje-cells) of the cerebellum, where it mediates calcium influx necessary for neurotransmitter release and dendritic excitability.

The CACNA1A gene is one of the most neurologically important calcium channel genes, with mutations causing multiple allelic disorders including:

• Spinocerebellar Ataxia Type 6 (SCA6)
• Familial Hemiplegic Migraine Type 1 (FHM1)
• Episodic Ataxia Type 2 (EA2)
• Epileptic encephalopathy

Gene Structure and Normal Function

Gene Organization

The CACNA1A gene is located on chromosome 19p13.13 and spans approximately 350 kb. It consists of 47 exons encoding the alpha-1A subunit of the P/Q-type calcium channel. The CAG repeat expansion responsible for SCA6 is located in the 3' coding region of the gene[@matsushita1999].

Protein Structure

The CaV2.1 channel is a large transmembrane protein (~2500 amino acids) with:

• S1-S6 transmembrane segments in each of four homologous domains (I-IV)
• Voltage-sensing domain (S1-S4) that detects membrane depolarization
• P-loop region (S5-S6) forming the ion conduction pore
• C-terminal tail containing interaction domains for regulatory proteins
• Multiple splice variants creating functionally diverse channel isoforms

Channel Function in Cerebellar Circuitry

The P/Q-type calcium channel plays critical roles in cerebellar function:

Synaptic Transmission: CaV2.1 channels are essential for neurotransmitter release at parallel fiber-Purkinje cell synapses and climbing fiber-Purkinje cell synapses. The channel's high voltage sensitivity and rapid inactivation properties make it ideal for precise temporal control of synaptic signaling.

Dendritic Excitability: In Purkinje cell dendrites, P/Q channels mediate calcium influx in response to excitatory synaptic input, triggering long-term depression (LTD) — a key mechanism for cerebellar learning.

Pacemaker Activity: In cerebellar interneurons and some neuronal populations, CaV2.1 channels contribute to rhythmic firing patterns essential for motor coordination.

Pathophysiology of SCA6

Molecular Mechanism of Polyglutamine Expansion

The SCA6 mutation involves CAG trinucleotide repeat expansion in the CACNA1A gene, producing an expanded polyglutamine (polyQ) tract in the resulting protein[@watase2008]. Key aspects include:

Normal Repeat Length: 4-16 CAG repeats Pathogenic Range: 20-33 repeats Anticipation: Larger repeats correlate with earlier onset and more severe disease

Gain-of-Function Mechanism

Unlike many polyglutamine diseases, SCA6 appears to involve both channel dysfunction and toxic gain-of-function mechanisms:

Channel Dysfunction:

• Altered channel gating properties
• Reduced current density in Purkinje cells
• Impaired synaptic plasticity
• Abnormal calcium homeostasis[@du2013]

• Polyglutamine-containing protein aggregates
• Transcriptional dysregulation
• Mitochondrial dysfunction
• Oxidative stress[@torrente2011]

Cerebellar Pathology

SCA6 is characterized by selective degeneration of [Purkinje cells](/cell-types/purkinje-cells)[@cvetkovic2004]:

Neuropathological Features:

• Severe Purkinje cell loss in the cerebellar cortex
• Atrophy of the cerebellar vermis
• Degeneration of inferior olive nuclei
• Relative sparing of other cerebellar neuron types
• Minimal involvement of extra-cerebellar regions

• Impaired P/Q channel function leads to reduced calcium signaling
• Disrupted synaptic plasticity at parallel fiber-Purkinje cell synapses
• Progressive Purkinje cell degeneration
• Dysfunction of cerebellar output pathways[@kordas2016]

Calcium Dyshomeostasis in SCA6

Intracellular Calcium Dysregulation

Calcium homeostasis is profoundly disrupted in SCA6[@satput2018][@migliore2021]:

ER Calcium Depletion: P/Q channel dysfunction disrupts calcium release from endoplasmic reticulum stores, impairing calcium-dependent signaling pathways.

Mitochondrial Calcium Overload: Secondary mitochondrial calcium dysregulation leads to metabolic dysfunction and apoptosis.

Calpain Activation: Dysregulated calcium activates calpain proteases, contributing to protein degradation and cell death.

Impact on Signaling Pathways

Calcium dyshomeostasis affects multiple downstream pathways:

PKC and CaMKII: Altered calcium-dependent kinase activation affects synaptic plasticity mechanisms.

cAMP/PKA Signaling: P/Q channels modulate cAMP levels, affecting neuronal excitability.

ERK/MAPK Pathway: Calcium-dependent MAPK activation is disrupted, impacting cell survival.

NF-κB Signaling: Calcium dysregulation influences inflammatory responses in cerebellar cells.

Disease Phenotypes

Spinocerebellar Ataxia Type 6

Clinical Features[@yabe2003][@soong2005]:

• Progressive cerebellar ataxia (gait, limb, speech)
• Dysarthria (slurred speech)
• Nystagmus (involuntary eye movements)
• Vertigo and balance problems
• Late-onset (typically 40-60 years)

• Slowly progressive over decades
• Moderate disability in later stages
• Life expectancy generally normal
• Variable intrafamilial severity

Familial Hemiplegic Migraine Type 1

FHM1 is caused by different CACNA1A mutations (gain-of-function) than SCA6:

• Transient hemiparesis during migraine attacks
• Cerebellar ataxia in some families
• Seizures possible
• Aura symptoms typical

Episodic Ataxia Type 2

CACNA1A loss-of-function mutations cause EA2:

• Episodic ataxia episodes (hours to days)
• Between-episode ataxia (mild)
• Responds to acetazolamide treatment

Expression Pattern

Brain Regional Distribution

P/Q-type calcium channel (CaV2.1) shows high expression in:

Cerebellum:

• Purkinje cells (highest expression)
• Cerebellar interneurons (basket cells, stellate cells)
• Deep cerebellar nuclei

• Inferior olive nuclei
• Cochlear nuclei
• Vestibular nuclei

• Layer 5 pyramidal neurons
• Hippocampal CA1 neurons

Cell-Type Specificity

The channel is particularly enriched in neurons requiring P/Q-mediated calcium influx for:

• High-frequency synaptic transmission
• Precision timing in sensory processing
• Synaptic plasticity mechanisms

Animal Models

SCA6 Knockin Mice

Mouse models expressing expanded CAG repeats in CACna1a demonstrate[@watase2008]:

• Progressive Purkinje cell degeneration
• Ataxic gait and motor coordination deficits
• Abnormal calcium handling
• Synaptic transmission deficits

Key Findings from Models

• Purkinje cell-specific vulnerability
• Age-dependent disease progression
• Rescue with channel modulators
• Therapeutic target validation

Therapeutic Approaches

Current Symptomatic Treatments

| Approach | Mechanism | Status |
|----------|-----------|--------|
| Acetazolamide | Carbonic anhydrase inhibitor | EA2 approved, some SCA6 benefit |
| 4-Aminopyridine | Potassium channel blocker | Reduces ataxia symptoms |
| Amantadine | NMDA antagonist | Mixed results |
| Riluzole | Multi-modal | Clinical trials ongoing |

Disease-Modifying Strategies

Gene Therapy Approaches[@zhang2019][@cuny2022]:

• RNA interference to reduce mutant allele expression
• CRISPR-based gene editing
• Delivery of wild-type CACNA1A
• Polyglutamine aggregation inhibitors

• L-type calcium channel blockers
• SERCA pump enhancers
• Mitochondrial protectants
• Calcium chelators

• Antioxidant therapy
• Anti-apoptotic agents
• neurotrophic factors
• Exercise and rehabilitation

Interaction Network

Protein-Protein Interactions

The CaV2.1 channel interacts with multiple regulatory proteins[@marqueze2015]:

Channel-Associated Proteins:

• α2δ-1 subunit (auxiliary subunit)
• β1-4 subunits (auxiliary subunits)
• Syntaxin 1A
• SNAP-25
• Synaptotagmin

• RYR3 (ryanodine receptor)
• CaBP1 (calcium-binding protein)
• Homer proteins
• PSD-95 family

Signaling Pathways

P/Q channels modulate:

• cAMP/PKA Pathway: Through Gi/o protein coupling
• MAPK/ERK Pathway: Calcium-dependent activation
• PI3K/Akt Pathway: Cell survival signaling
• NFAT Transcription: Calcium-dependent gene expression

Cross-Linking to Related Mechanisms

Related Neurodegenerative Diseases

• [Spinocerebellar Ataxias](/diseases/spinocerebellar-ataxia) — Disease family
• [Ataxia](/mechanisms/ataxia) — Symptom mechanism
• [Polyglutamine Diseases](/mechanisms/polyglutamine-diseases) — Shared mechanism
• [Calcium Signaling](/mechanisms/calcium-signaling) — Pathway dysfunction
• [Purkinje Cells](/cell-types/purkinje-cells) — Affected cell type

Related Genes and Proteins

• [CACNB4](/genes/cacnb4) — Auxiliary subunit mutations cause SCA
• [CACNA1E](/genes/cacna1e) — Related R-type channel
• [RYR1](/genes/ryr1) — Related calcium release channel

Research Methods

Genetic Diagnosis

• PCR-based CAG repeat sizing
• Fragment analysis
• Next-generation sequencing panels
• Whole exome sequencing

Biomarkers

• Serum/CSF neurofilament light chain
• MRI cerebellar volumetry
• Quantitative motor assessments
• Eye movement recordings

Therapeutic Development

• Patient-derived iPSC models
• CRISPR screening
• High-throughput drug screens
• Gene therapy vectors

Future Directions

Key Research Questions

Emerging Therapies

• Antisense oligonucleotides
• Small molecule channel modulators
• Gene replacement therapy
• Cell replacement approaches

See Also

• [Spinocerebellar Ataxia Type 6](/diseases/spinocerebellar-ataxia-type-6)
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Related calcium dysfunction
• [Parkinson's Disease](/diseases/parkinsons-disease) — Related channelopathies
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Similar mechanism
• [Calcium Signaling](/mechanisms/calcium-signaling)
• [Purkinje Cells](/cell-types/purkinje-cells)
• [Voltage-Gated Calcium Channels](/mechanisms/voltage-gated-calcium-channels)

External Links

• [NCBI Gene: CACNA1A](https://www.ncbi.nlm.nih.gov/gene/774)
• [UniProt: Q00978](https://www.uniprot.org/uniprotkb/Q00978)
• [OMIM: 117013](https://www.omim.org/entry/117013)
• [Ensembl: ENSG00000159289](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000159289)
• [ClinVar: CACNA1A variants](https://www.ncbi.nlm.nih.gov/clinvar/?term=CACNA1A)

References